Bio-Rad Laboratories (BIO-B) Long-Term Investments (2012 - 2026)

Bio-Rad Laboratories (BIO-B) has 15 years of Long-Term Investments data on file, last reported at $5.3 billion in Q1 2026.

• Quarterly Long-Term Investments rose 6.36% year-over-year to $5.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.3 billion (up 6.36% YoY) and the FY2025 annual result came in at $6.1 billion, up 26.13% from the prior year.
• Long-Term Investments retreated to $5.3 billion in Q1 2026 per BIO-B's latest filing, from $6.1 billion in the prior quarter.
• Across five years, Long-Term Investments topped out at $9.7 billion in Q1 2022 and bottomed at $4.8 billion in Q4 2024.
• The 5-year median for Long-Term Investments is $7.2 billion (2023), against an average of $6.8 billion.
• The widest annual swing landed in 2022, when Long-Term Investments slumped 54.04%; it then rose 26.13% in 2025.
• Tracing BIO-B's Long-Term Investments over 5 years: stood at $8.8 billion in 2022, then slipped by 12.83% to $7.7 billion in 2023, then sank by 37.14% to $4.8 billion in 2024, then rose by 26.13% to $6.1 billion in 2025, then decreased by 12.97% to $5.3 billion in 2026.
• Per Business Quant, the three latest BIO-B Long-Term Investments figures stand at $5.3 billion (Q1 2026), $6.1 billion (Q4 2025), and $5.1 billion (Q3 2025).

Peer Comparison